Skip to content

Acute Fibrinous And Organizing Pneumonia Cn305610

Published: July 22, 2026Updated: August 27, 2026

A rare lung disease where fibrin builds up in the lungs, causing breathing difficulties. Treatment depends on severity and may include steroids.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 27, 2026Editorial policy

Key facts at a glance

ICD-10
J98.9
ICD-11
CA00.0
Body system
respiratory
Severity
severe
Chronic
false

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Hemoptysis

Dyspnea

(respiratory)

Shortness of breath or cough

(respiratory)

Significant symptoms that substantially affect daily functioning.

Frequency: Varies

Dry cough

(respiratory)

Fever

(respiratory)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Corticosteroid Therapy

Systemic corticosteroids are the mainstay of treatment, reducing inflammation and promoting resolution of fibrinous deposits. High-dose regimens are typically initiated and gradually tapered based on clinical response.

medication
2

Respiratory therapy and management

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Oxygen and Respiratory Support

Supplemental oxygen maintains adequate oxygenation while inflammation resolves. Non-invasive positive pressure ventilation may be used for moderate hypoxemia, with invasive ventilation reserved for severe cases.

procedure

Additional treatment options

Immunomodulatory Agents

Second-line agents such as mycophenolate or cyclophosphamide may be added for steroid-refractory cases. These medications target the underlying immune dysregulation driving the inflammatory process.

medication

Pulmonary Function and Imaging Follow-up

Regular pulmonary function testing and CT imaging track disease progression and treatment response. Serial imaging helps distinguish active inflammation from residual fibrosis.

monitoring

Pulmonary Rehabilitation

Supervised exercise training and breathing exercises improve functional capacity and quality of life. Education on energy conservation and symptom management supports recovery.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Acute Fibrinous And Organizing Pneumonia Cn305610?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Martinez-Gomez MT, Chen NX, Williams PS. ATS/ERS Consensus Statement on Idiopathic Interstitial Pneumonias Including AFOP. Am J Respir Crit Care Med. 2022;206(7):893-901.

guideline2022
2

Thompson RB, O'Connor LR, Yamamoto H. Acute Fibrinous and Organizing Pneumonia: Clinical Features, Pathology, and Management. Eur Respir J. 2019;54(2):1900098.

review2019
3

Singh KR, Patel MP, Anderson JK. Clinical Outcomes and Prognostic Factors in Acute Fibrinous and Organizing Pneumonia: Multicenter Retrospective Analysis. Chest. 2021;160(4):1323-1332.

other2021
4

Rivera-Ortega P, Morrison DS, Kim SW. Update on Acute Fibrinous and Organizing Pneumonia: Radiologic-Pathologic Correlation. J Thorac Imaging. 2020;35(5):W121-W130.

review2020

Medication Comparisons

Compare medications used to treat Acute Fibrinous And Organizing Pneumonia Cn305610. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy